Clifford Chance is advising private equity firm CVC Capital Partners on its $1.1 billion privatisation of Hong Kong-listed Nirvana, Asia's largest funeral services firm, which is being represented by Sullivan & Cromwell and Conyers Dill & Pearman.

CVC is offering HK$3 per share in cash, a premium of 22.4 percent over its last trading price, to the company founder and other shareholders of Nirvana, as reported by Reuters.

The Clifford Chance team working on the deal is being led by partners Andrew Whan and Neeraj Budhwani. 

J.P. Morgan, CVC’s financial adviser on the deal, is being represented by a Kirkland & Ellis team that includes corporate partners Nicholas Norris and Joey Chau, and debt finance partner David Irvine.

 

Related Articles

Deals

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Deals

Haiwen, CC advise on China TCM's $2 bln take-private deal

by Hu Yangxiaoxiao 胡阳潇潇 |

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

Deals

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.